|
1
|
Galli SJ, Tsai M and Piliponsky AM: The
development of allergic inflammation. Nature. 454:445–454. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Simons FE: Anaphylaxis. J Allergy Clin
Immunol. 125 2 Suppl 2:S161–S181. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Choi EJ, Lee S, Hwang JS, Im SH, Jun CD,
Lee HS and Kim SH: DA-9601 suppresses 2, 4-dinitrochlorobenzene and
dust mite extract-induced atopic dermatitis-like skin lesions. Int
Immunopharmacol. 11:1260–1264. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Furue M, Terao H, Rikihisa W, Urabe K,
Kinukawa N, Nose Y and Koga T: Clinical dose and adverse effects of
topical steroids in daily management of atopic dermatitis. Br J
Dermatol. 148:128–133. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Leung DY, Jain N and Leo HL: New concepts
in the pathogenesis of atopic dermatitis. Curr Opin Immunol.
15:634–638. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Galli SJ, Nakae S and Tsai M: Mast cells
in the development of adaptive immune responses. Nat Immunol.
6:135–142. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Caramalho I, Lopes-Carvalho T, Ostler D,
Zelenay S, Haury M and Demengeot J: Regulatory T cells selectively
express toll-like receptors and are activated by
lipopolysaccharide. J Exp Med. 197:403–411. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yamamoto S, Kuramoto E, Shimada S and
Tokunaga T: In vitro augmentation of natural killer cell activity
and production of interferon-alpha/beta and -gamma with
deoxyribonucleic acid fraction from Mycobacterium bovis BCG. Jpn J
Cancer Res. 79:866–873. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yamamoto S, Yamamoto T, Kataoka T,
Kuramoto E, Yano O and Tokunaga T: Unique palindromic sequences in
synthetic oligonucleotides are required to induce IFN [correction
of INF] and augment IFN-mediated [correction of INF] natural killer
activity. J Immunol. 148:4072–4076. 1992.PubMed/NCBI
|
|
10
|
Fujieda S, Iho S, Kimura Y, Sunaga H,
Igawa H, Sugimoto C, Yamamoto S and Saito H: DNA from mycobacterium
bovis bacillus Calmette-Guérin (MY-1) inhibits immunoglobulin E
production by human lymphocytes. Am J Respir Crit Care Med.
160:2056–2061. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cheng D, Zheng B, Chen W and Chen Z: The
prophylactic effect of BCG polysaccharides nucleic acid on the
acute attack of chronic obstructive pulmonary disease. Hua Xi Yi Ke
Da Xue Xue Bao. 33:121–122. 2002.(In Chinese). PubMed/NCBI
|
|
12
|
Xiong C, Li Q, Lin M, Li X, Meng W, Wu Y,
Zeng X, Zhou H and Zhou G: The efficacy of topical intralesional
BCG-PSN injection in the treatment of erosive oral lichen planus: A
randomized controlled trial. J Oral Pathol Med. 38:551–558. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Deng T, Liu B, Duan X, Zhang T, Cai C and
Zeng G: Systematic review and cumulative analysis of the
combination of mitomycin C plus Bacillus Calmette-Guérin (BCG) for
non-muscle-invasive bladder cancer. Sci Rep. 7:31722017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jin YJ, Song ZY, Hu Y, Qian XB, Wang XY
and He XY: Effects of montelukast and BCG-PSN on the expression of
STAT5b mRNA and IL-4 mRNA in blood mononuclearcells of rats with
asthma. Zhongguo Dang Dai Er Ke Za Zhi. 11:133–137. 2009.(In
Chinese). PubMed/NCBI
|
|
15
|
Zuo CX, Huang JH, Liao ZH, Lu JY and Chen
J: Effects of BCG-PSN on serum levels of IL-4 and IL-12 in patients
with condyloma acuminatum. Zhong Nan Da Xue Xue Bao Yi Xue Ban.
29:690–692. 2004.(In Chinese). PubMed/NCBI
|
|
16
|
Sun M, Wang S, Zhao L, Zhao H, Yao W, Jin
W and Wei M: Suppression of 2,4-dinitrochlorobenzene-induced atopic
dermatitis by extract of Bacillus Calmette-Guerin. Mol Med Rep.
9:689–694. 2014.PubMed/NCBI
|
|
17
|
Cho A and Seok SH: Ethical guidelines for
use of experimental animals in biomedical research. J Bacteriol
Virol. 43:18–26. 2013. View Article : Google Scholar
|
|
18
|
Finkelman FD: Anaphylaxis: Lessons from
mouse models. J Allergy Clin Immunol. 120:506–515; quiz 516–517.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Inagaki N and Nagai H: Analysis of the
mechanism for the development of allergic skin inflammation and the
application for its treatment: Mouse models for the development of
remedies for human allergic dermatitis. J Pharmacol Sci.
110:251–259. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Evora PR and Simon MR: Role of nitric
oxide production in anaphylaxis and its relevance for the treatment
of anaphylactic hypotension with methylene blue. Ann Allergy Asthma
Immunol. 99:306–313. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kumar P, Shen Q, Pivetti CD, Lee ES, Wu MH
and Yuan SY: Molecular mechanisms of endothelial hyperpermeability:
Implications in inflammation. Expert Rev Mol Med. 11:e192009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Matsuoka H, Maki N, Yoshida S, Arai M,
Wang J, Oikawa Y, Ikeda T, Hirota N, Nakagawa H and Ishii A: A
mouse model of the atopic eczema/dermatitis syndrome by repeated
application of a crude extract of house-dust mite Dermatophagoides
farinae. Allergy. 58:139–145. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim SH, Jun CD, Suk K, Choi BJ, Lim H,
Park S, Lee SH, Shin HY, Kim DK and Shin TY: Gallic acid inhibits
histamine release and pro-inflammatory cytokine production in mast
cells. Toxicol Sci. 91:123–131. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kang JS, Yoon WK, Han MH, Lee H, Lee CW,
Lee KH, Han SB, Lee K, Yang KH, Park SK and Kim HM: Inhibition of
atopic dermatitis by topical application of silymarin in NC/Nga
mice. Int Immunopharmacol. 8:1475–1480. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sullivan TJ, Parker KL, Kulczycki A Jr and
Parker CW: Modulation of cyclic AMP in purified rat mast cells.
III. Studies on the effects of concanavalin A and anti-IgE on
cyclic AMP concentrations during histamine release. J Immunol.
117:713–716. 1976.PubMed/NCBI
|
|
26
|
Kurosawa M, Mori H, Nagai H and Koda A:
Change in the activity of the cyclic AMP-dependent protein kinase
in antigen-stimulated sensitized mast cells and effect of drugs
inhibiting allergic mediator release. Jpn J Pharmacol. 43:454–457.
1987. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kurosawa M: Studies of phosphorylation in
rat mast cells (sixth report). Cyclic AMP-dependent protein
phosphorylation in rat mast cell granule membranes. Nihon
Yakurigaku Zasshi. 86:87–92. 1985.(In Japanese). View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sullivan TJ, Parker KL, Eisen SA and
Parker CW: Modulation of cyclic AMP in purified rat mast cells. II.
Studies on the relationship between intracellular cyclic AMP
concentrations and histamine release. J Immunol. 114:1480–1485.
1975.PubMed/NCBI
|
|
29
|
Lau HY and Chan CL: Modulation of
intracellular cyclic AMP in immunologically activated rat
peritoneal mast cells by prostaglandin D2. Inflamm Res. 50 Suppl
2:S61–S62. 2001.PubMed/NCBI
|
